Neurologic complications of lung cancer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Neurologic complications of lung cancer are a frequent cause of morbidity and mortality. Tumor metastasis to the brain parenchyma is the single most common neurologic complication of lung cancer, of any histologic subtype. The goal of radiation therapy and in some cases surgical resection for patients with brain metastases is to improve or maintain neurologic function, and to achieve local control of the brain lesion(s).Metastasis of lung cancer to the spinal epidural space requires urgent evaluation and treatment. Early diagnosis and modern surgical and radiotherapy techniques improve neurologic outcome for most patients. Leptomeningeal metastasis is a less common but ominous occurrence in patients with lung cancer. Lung carcinomas can also occasionally metastasize to the brachial plexus, skull base, dura, or pituitary.Paraneoplastic neurologic disorders are uncommon but important complications of lung carcinoma, and are generally the presenting feature of the tumor. Paraneoplastic disorders are believed to be caused by an autoimmune humoral or cellular attack against shared "onconeural" antigens. The most frequent paraneoplastic disorders in patients with lung cancer are Lambert-Eaton myasthenic syndrome, and multifocal paraneoplastic encephalomyelitis, both mainly occurring in association with small-cell lung carcinoma. There is a variety of other paraneoplastic disorders affecting the central and peripheral nervous systems. Some affected patients have a good neurologic outcome, while others are left with severe permanent neurologic disability.

Original languageEnglish
Pages (from-to)335-361
Number of pages27
JournalHandbook of Clinical Neurology
Volume119
DOIs
StatePublished - 2014

Fingerprint

Nervous System
Lung Neoplasms
Neoplasm Metastasis
Nervous System Paraneoplastic Syndromes
Brain
Radiotherapy
Lambert-Eaton Myasthenic Syndrome
Carcinoma
Epidural Space
Lung
Brachial Plexus
Central Nervous System Diseases
Small Cell Lung Carcinoma
Skull Base
Peripheral Nervous System Diseases
Nervous System Diseases
Early Diagnosis
Neoplasms
Morbidity
Antigens

Keywords

  • Brain metastases
  • Lung carcinoma
  • Meningeal neoplasms
  • Paraneoplastic syndromes
  • Spine neoplasms

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Neurologic complications of lung cancer. / Dropcho, Edward.

In: Handbook of Clinical Neurology, Vol. 119, 2014, p. 335-361.

Research output: Contribution to journalArticle

@article{1be88faad6124902a0be7b5523e7e22a,
title = "Neurologic complications of lung cancer",
abstract = "Neurologic complications of lung cancer are a frequent cause of morbidity and mortality. Tumor metastasis to the brain parenchyma is the single most common neurologic complication of lung cancer, of any histologic subtype. The goal of radiation therapy and in some cases surgical resection for patients with brain metastases is to improve or maintain neurologic function, and to achieve local control of the brain lesion(s).Metastasis of lung cancer to the spinal epidural space requires urgent evaluation and treatment. Early diagnosis and modern surgical and radiotherapy techniques improve neurologic outcome for most patients. Leptomeningeal metastasis is a less common but ominous occurrence in patients with lung cancer. Lung carcinomas can also occasionally metastasize to the brachial plexus, skull base, dura, or pituitary.Paraneoplastic neurologic disorders are uncommon but important complications of lung carcinoma, and are generally the presenting feature of the tumor. Paraneoplastic disorders are believed to be caused by an autoimmune humoral or cellular attack against shared {"}onconeural{"} antigens. The most frequent paraneoplastic disorders in patients with lung cancer are Lambert-Eaton myasthenic syndrome, and multifocal paraneoplastic encephalomyelitis, both mainly occurring in association with small-cell lung carcinoma. There is a variety of other paraneoplastic disorders affecting the central and peripheral nervous systems. Some affected patients have a good neurologic outcome, while others are left with severe permanent neurologic disability.",
keywords = "Brain metastases, Lung carcinoma, Meningeal neoplasms, Paraneoplastic syndromes, Spine neoplasms",
author = "Edward Dropcho",
year = "2014",
doi = "10.1016/B978-0-7020-4086-3.00022-9",
language = "English",
volume = "119",
pages = "335--361",
journal = "Handbook of Clinical Neurology",
issn = "0072-9752",
publisher = "Elsevier",

}

TY - JOUR

T1 - Neurologic complications of lung cancer

AU - Dropcho, Edward

PY - 2014

Y1 - 2014

N2 - Neurologic complications of lung cancer are a frequent cause of morbidity and mortality. Tumor metastasis to the brain parenchyma is the single most common neurologic complication of lung cancer, of any histologic subtype. The goal of radiation therapy and in some cases surgical resection for patients with brain metastases is to improve or maintain neurologic function, and to achieve local control of the brain lesion(s).Metastasis of lung cancer to the spinal epidural space requires urgent evaluation and treatment. Early diagnosis and modern surgical and radiotherapy techniques improve neurologic outcome for most patients. Leptomeningeal metastasis is a less common but ominous occurrence in patients with lung cancer. Lung carcinomas can also occasionally metastasize to the brachial plexus, skull base, dura, or pituitary.Paraneoplastic neurologic disorders are uncommon but important complications of lung carcinoma, and are generally the presenting feature of the tumor. Paraneoplastic disorders are believed to be caused by an autoimmune humoral or cellular attack against shared "onconeural" antigens. The most frequent paraneoplastic disorders in patients with lung cancer are Lambert-Eaton myasthenic syndrome, and multifocal paraneoplastic encephalomyelitis, both mainly occurring in association with small-cell lung carcinoma. There is a variety of other paraneoplastic disorders affecting the central and peripheral nervous systems. Some affected patients have a good neurologic outcome, while others are left with severe permanent neurologic disability.

AB - Neurologic complications of lung cancer are a frequent cause of morbidity and mortality. Tumor metastasis to the brain parenchyma is the single most common neurologic complication of lung cancer, of any histologic subtype. The goal of radiation therapy and in some cases surgical resection for patients with brain metastases is to improve or maintain neurologic function, and to achieve local control of the brain lesion(s).Metastasis of lung cancer to the spinal epidural space requires urgent evaluation and treatment. Early diagnosis and modern surgical and radiotherapy techniques improve neurologic outcome for most patients. Leptomeningeal metastasis is a less common but ominous occurrence in patients with lung cancer. Lung carcinomas can also occasionally metastasize to the brachial plexus, skull base, dura, or pituitary.Paraneoplastic neurologic disorders are uncommon but important complications of lung carcinoma, and are generally the presenting feature of the tumor. Paraneoplastic disorders are believed to be caused by an autoimmune humoral or cellular attack against shared "onconeural" antigens. The most frequent paraneoplastic disorders in patients with lung cancer are Lambert-Eaton myasthenic syndrome, and multifocal paraneoplastic encephalomyelitis, both mainly occurring in association with small-cell lung carcinoma. There is a variety of other paraneoplastic disorders affecting the central and peripheral nervous systems. Some affected patients have a good neurologic outcome, while others are left with severe permanent neurologic disability.

KW - Brain metastases

KW - Lung carcinoma

KW - Meningeal neoplasms

KW - Paraneoplastic syndromes

KW - Spine neoplasms

UR - http://www.scopus.com/inward/record.url?scp=84890872003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890872003&partnerID=8YFLogxK

U2 - 10.1016/B978-0-7020-4086-3.00022-9

DO - 10.1016/B978-0-7020-4086-3.00022-9

M3 - Article

C2 - 24365305

AN - SCOPUS:84890872003

VL - 119

SP - 335

EP - 361

JO - Handbook of Clinical Neurology

JF - Handbook of Clinical Neurology

SN - 0072-9752

ER -